LAS VEGAS, March 03, 2022 (GLOBE NEWSWIRE) — Alkame Holdings Inc. (USOTC: ALKM) and Puration, Inc. (USOTC: PURA) are pleased to announce initial delivery of EVERx Sugar Free CBD Sports Water, underway showing today at the Arnold Sports Festival in Columbus Ohio.
ALKM has worked with PURA since the beginning with the formulation, development and production of the EVERx CBD sports water brand. In addition to the original EVERx Sports Water, EVERx will now be available in sugar-free flavors: Kiwi Strawberry and Lemon Lime.
About West Coast Co Packer, Inc.
West Coast Co Packer, Inc., is a wholly owned subsidiary of Alkame Holdings, Inc. and is a specialty liquid and single-serving manufacturer, co-packer, private labeler and contract manufacturer, and is expected to immediately complement and seamlessly integrate with other Alkame subsidiaries, including Bell Food and Beverage, Inc. Bell Food and Beverage, Inc. is a specialty manufacturer of natural and organic liquid-based foods and beverages, hot-filled and cold in glass and PET bottles and jars. To learn more about West Coast Copacker, visit www.westcoastcopacker.com.
About Alkame Holdings, Inc.
Alkame Holdings, Inc. is a publicly traded health and wellness technology holding company focused on patentable, innovative and environmentally friendly consumer products. The Company’s wholly-owned subsidiaries manufacture products with enhanced water using proprietary technology to create products with several unique properties. The organization is diligently building a solid foundation through launching and acquiring suitable business assets, and pursuing multiple applications by placing them in several emerging business sectors, such as consumer bottled water and RTD products. , household pet products, horticultural and agricultural applications, hand sanitizers and many other water-based treatment solutions for new and existing commercial platforms.
For more information, visit www.alkameholdingsinc.com.
Alkame Holdings, Inc. Investor Relations
Email: [email protected]
Disclaimer/Safe Harbor: This press release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. Statements reflect the Company’s current beliefs regarding future events that involve risks and uncertainties. These risks include, among others, the expectation that Alkame will achieve significant sales, failure to meet deadlines or performance requirements of the Company’s contracts, the Company’s liquidity position, the Company’s ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive prices. In light of these uncertainties, the forward-looking events discussed in this press release may not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.